Learn More
Medchemexpress LLC Tezacaftor-d4 | 1961280-24-9 | C26H23D4F3N2O6 | 500 UG

Supplier: Medchemexpress LLC HY15448S500UG
Tezacaftor-d4 (VX-661-d4) is a deuterium-labeled variant of Tezacaftor, an F508del CFTR corrector. It aids the CFTR protein in reaching the cell surface and is valuable as a tracer and internal standard for quantitative analysis, particularly in drug development. Its deuterium incorporation can influence pharmacokinetic and metabolic profiles. When combined with Ivacaftor, Tezacaftor exhibits significant efficacy against cystic fibrosis and related conditions with the homozygous CFTR Phe508del mutation.
- Deuterium-labeled F508del CFTR corrector
- Assists CFTR protein trafficking to the cell surface
- Useful as a tracer and internal standard
- Incorporation of stable heavy isotopes for quantitation in drug development
- Potential to impact pharmacokinetic and metabolic profiles
- Potent efficacy against cystic fibrosis when combined with Ivacaftor
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.